AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REGENERON PHARMACEUTICALS, INC. Director's Dealing 2012

Feb 13, 2012

29977_dirs_2012-02-13_79f229a9-0433-4eb2-8749-e110e8db68e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2011-12-31

Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-05	Common Stock	G	3509	—	Disposed	171547	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	40087	Direct
Common Stock	100000	Indirect
Common Stock	2271	Indirect
Common Stock	94222	Indirect
Common Stock	160000	Indirect
Common Stock	1203	Indirect

Footnotes

F1: By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.

F2: By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.